9/11/23 09:19 | 8/30/23 | NRXP | Health | Drug | Pharmaceutical Preparations | Gorovitz Aaron | DE | D | | P | 11 | 0.3199 | 0 | 35 | 50 | 105 | I | | | | | | | | | | | | | | |
9/11/23 09:15 | 8/30/23 | NRXP | Health | Drug | Pharmaceutical Preparations | Hurvitz Chaim | DE | D | | P | 20 | 0.2875 | 0 | 70 | 3 | 2,215 | D | | | | | | | | | | | | | | |
8/24/23 12:14 | 8/23/23 | NRXP | Health | Drug | Pharmaceutical Preparations | Javitt Jonathan C | DE | DOT | Chief Sc | P | 33 | 0.3300 | 0 | 100 | 1 | 14,768 | D | | | | | | | | | | | | | | |
8/23/23 09:24 | 8/22/23 | NRXP | Health | Drug | Pharmaceutical Preparations | Javitt Jonathan C | DE | DOT | Chief Sc | P | 64 | 0.3220 | 0 | 200 | 1 | 14,668 | D | | | | | | | | | | | | | | |
12/19/22 07:14 | 12/16/22 | NRXP | Health | Drug | Pharmaceutical Preparations | Willard Stephen H | DE | DO | CEO | P | 59 | 1.17 | 0 | 50 | New | 50 | D | | | | | | | | | | | | | | |
12/19/22 07:09 | 12/16/22 | NRXP | Health | Drug | Pharmaceutical Preparations | Van Voorhees Seth | DE | O | CFO | P | 33 | 1.10 | 0 | 30 | 184 | 46 | D | | | | | | | | | | | | | | |
12/19/22 07:08 | 11/25/22 | NRXP | Health | Drug | Pharmaceutical Preparations | Van Voorhees Seth | DE | O | CFO | P.a | 18 | 1.11 | 0 | 16 | New | 16 | D | | | | | | | | | | | | | | |
12/9/22 16:33 | 12/7/22 | NRXP | Health | Drug | Pharmaceutical Preparations | Javitt Jonathan C | DE | DT | | S | -400 | 1.00 | 0 | -400 | -3 | 14,468 | I | | | | | | | | | | | | | | |
12/1/22 19:29 | 11/29/22 | NRXP | Health | Drug | Pharmaceutical Preparations | Javitt Daniel C. | DE | T | | S.m | -33 | 1.50 | 0 | -22 | 0 | 9,635 | I | | | | | | | | | | | | | | |
11/29/22 07:00 | 11/28/22 | NRXP | Health | Drug | Pharmaceutical Preparations | Flynn Patrick John | DE | D | | P | 15 | 1.25 | 0 | 12 | 39 | 42 | M | | | | | | | | | | | | | | |
11/28/22 07:42 | 11/25/22 | NRXP | Health | Drug | Pharmaceutical Preparations | Van Voorhees Seth | DE | O | CFO | P | 18 | 1.11 | 0 | 16 | 999% | 16 | I | | | | | | | | | | | | | | |
11/23/22 16:09 | 11/16/22 | NRXP | Health | Drug | Pharmaceutical Preparations | Hurvitz Chaim | DE | D | | P.am | 515 | 1.03 | 0 | 500 | New | 500 | D | | | | | | | | | | | | | | |
11/21/22 17:58 | 11/16/22 | NRXP | Health | Drug | Pharmaceutical Preparations | Hurvitz Chaim | DE | D | | P.dm | 515 | 1.03 | 0 | 500 | 30 | 2,145 | D | | | | | | | | | | | | | | |
11/18/22 19:05 | 11/16/22 | NRXP | Health | Drug | Pharmaceutical Preparations | Javitt Daniel C. | DE | T | | S.m | -171 | 1.03 | 0 | -167 | -2 | 9,657 | I | | | | | | | | | | | | | | |
11/15/22 19:40 | 11/11/22 | NRXP | Health | Drug | Pharmaceutical Preparations | Javitt Daniel C. | DE | T | | S | -50 | 1.01 | 0 | -49 | 0 | 9,824 | I | | | | | | | | | | | | | | |
8/2/22 17:43 | 7/29/22 | NRXP | Health | Drug | Pharmaceutical Preparations | Javitt Daniel C. | DE | T | | S | -791 | 1.01 | 0 | -784 | -7 | 9,873 | I | | | | | | | | | | | | | | |
6/7/22 20:11 | 6/3/22 | NRXP | Health | Drug | Pharmaceutical Preparations | Javitt Daniel C. | DE | T | | S.m | -304 | 0.6819 | 0 | -446 | -3 | 12,657 | I | | | | | | | | | | | | | | |
6/2/22 09:46 | 6/1/22 | NRXP | Health | Drug | Pharmaceutical Preparations | Javitt Jonathan C | DE | DOT | Chief Sc | P.a | 58 | 0.5800 | 0 | 100 | 1 | 14,868 | D | | | | | | | | | | | | | | |
6/2/22 08:55 | 6/1/22 | NRXP | Health | Drug | Pharmaceutical Preparations | Javitt Jonathan C | DE | DOT | Chief Sc | P | 5,800 | 58.00 | 0 | 100 | 1 | 14,868 | D | | | | | | | | | | | | | | |
11/2/21 16:07 | 8/26/21 | NRXP | Health | Drug | Pharmaceutical Preparations | McMaster Herbert Raymond | DE | D | | M.d | 41 | 2.22 | 0 | 18 | New | 18 | D | | | | | | | | | | | | | | |
11/2/21 16:05 | 8/19/21 | NRXP | Health | Drug | Pharmaceutical Preparations | Daigneault Alessandra | DE | O | GC,Secre | M.dm | 181 | 3.07 | 0 | 59 | | 32 | D | | | | | | | | | | | | | | |
11/2/21 16:05 | 8/23/21 | NRXP | Health | Drug | Pharmaceutical Preparations | Daigneault Alessandra | DE | O | GC,Secre | S.d | -442 | 13.11 | 0 | -34 | -52 | 32 | D | | | | | | | | | | | | | | |
11/2/21 16:04 | 8/16/21 | NRXP | Health | Drug | Pharmaceutical Preparations | Besthof Robert | DE | O | Chief Co | M.d | 13 | 0.2000 | 0 | 64 | | 24 | D | | | | | | | | | | | | | | |
11/2/21 16:04 | 9/15/21 | NRXP | Health | Drug | Pharmaceutical Preparations | Besthof Robert | DE | O | Chief Co | S.d | -470 | 11.76 | 0 | -40 | -63 | 24 | D | | | | | | | | | | | | | | |
3/17/20 16:37 | 3/13/20 | BRPA | Financ | AcqCo | Blank Checks | Polar Asset Management Partners Inc. | A6 | T | | S | -312 | 10.60 | 0 | -29 | -6 | 488 | I | | | | | | | | | | | | | | |
11/20/18 19:49 | 11/20/18 | BRPA | Financ | AcqCo | Blank Checks | Ackerman Richard | FL | DO | P,CEO | S | 0 | 0.00 | 0 | -1,500 | -75 | 498 | I | | | | | | | | | | | | | | |
12/4/17 20:23 | 11/29/17 | BRPAU | Financ | AcqCo | Blank Checks | Ackerman Richard | FL | DOT | P,CEO | P.d | 225 | 10.00 | 0 | 23 | 1 | 1,998 | I | | | | | | | | | | | | | | |